Skip to main content
CDC Website

Webpage

Hepatitis B and your cancer risk

This article provides a comprehensive overview of hepatitis B (HBV) and its relationship to liver cancer and other potential health risks. Hepatitis B is a viral infection transmitted through infected blood and bodily fluids, which can lead to liver inflammation, fibrosis, cirrhosis, and ultimately liver cancer. The article emphasizes that HBV can be asymptomatic, making screening critical for early detection and prevention.

HPV Vaccinations Found To Protect Both Vaccinated and Unvaccinated Women

This long-term population study examines the real-world effectiveness of human papillomavirus (HPV) vaccines in preventing HPV infections among adolescent and young adult women, including those who remained unvaccinated. Conducted in Cincinnati from 2006 to 2023 and involving 2,335 participants aged 13–26, the research evaluated the impact of the 2-, 4-, and 9-valent HPV vaccines as community vaccination rates rose from 0% to 82% over 17 years.

Study finds new program to enhance HIV screening dramatically boosts testing in urgent care clinics and emergency departments

This study describes the development and implementation of a comprehensive HIV co-testing initiative across Intermountain Health’s urgent care clinics and emergency departments. The program was designed to standardize HIV screening for patients undergoing evaluation for sexually transmitted infections, addressing historically low HIV testing rates in Utah. Key components included clinician and patient education, electronic health record alerts prompting HIV test orders when appropriate, and a structured link-to-care system to ensure rapid follow-up for newly diagnosed individuals.

Five things to know about tuberculosis as it surfaces in Maine and North Carolina

Recent weeks have seen a handful of new Tuberculosis (TB) cases reported in states including Maine, North Carolina and California. While TB is rare in the U.S., even a single active case warrants attention. This article provides an overview of what TB is & how it spreads. TB is caused by a bacterium (Mycobacterium tuberculosis) that typically attacks the lungs, forming lesions called “tubercles,” and can destroy lung tissue — severe disease can lead to respiratory failure.

Aging With HIV Cheat Sheet

The “Aging With HIV Cheat Sheet” provides practical, research-informed guidance for people living with HIV who are growing older — reflecting that many people with HIV now live well into middle age and beyond. It recognizes that as people with HIV age, their health needs evolve — combining general aging challenges with HIV-specific risks. 
Why aging with HIV matters more now:
•    In the U.S., more than half of people living with HIV are now aged 50 or older.

Can you get HIV from someone on PrEP?

This article provides a comprehensive overview of pre-exposure prophylaxis (PrEP), a highly effective HIV prevention medication for people who are HIV-negative and at increased risk of acquiring the virus. It explains that when taken as prescribed, PrEP reduces HIV transmission risk by about 99%, making the chance of contracting HIV from someone correctly using PrEP extremely low.

High-Risk HIV Behaviors - Women: State

This report provides an overview of high-risk HIV behaviors among women ages 18–44 in the United States, based on national surveillance data from the Behavioral Risk Factor Surveillance System (BRFSS). High-risk behaviors include injecting non-prescribed drugs, receiving treatment for a sexually transmitted infection, and exchanging sex for money or drugs within the past year. These behaviors are key indicators of HIV vulnerability and often reflect broader social and structural factors such as access to health care, substance use patterns, and economic instability.

What to know about tuberculosis as it surfaces in Maine and North Carolina. Who is at risk?

This article reviews key clinical and public health considerations surrounding recent tuberculosis (TB) cases reported in Maine, North Carolina, and California. Although TB remains relatively rare in the United States, it continues to cause more than 1 million deaths annually worldwide and poses ongoing risks, particularly for individuals with weakened immune systems or those who live or work in congregate settings.